You have 9 free searches left this month | for more free features.

rg1507

Showing 1 - 9 of 9

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer Trial in United States (RG1507, Letrozole)

Terminated
  • Breast Cancer
  • Birmingham, Alabama
  • +5 more
Oct 20, 2020

Non-Squamous NSCLC Trial in Worldwide (Placebo, RG1507, erlotinib [Tarceva])

Terminated
  • Non-Squamous Non-Small Cell Lung Cancer
  • Placebo
  • +2 more
  • Beverly Hills, California
  • +56 more
Dec 5, 2020

Sarcoma Trial in Worldwide (RG1507)

Terminated
  • Sarcoma
  • RG1507
  • Duarte, California
  • +40 more
Jan 14, 2021

Tumors Trial in United States (RG1507)

Completed
  • Neoplasms
  • RG1507
  • Tucson, Arizona
  • +5 more
Oct 29, 2016

Tumors Trial in Aurora, New Brunswick, Houston (RG1507)

Completed
  • Neoplasms
  • RG1507
  • Aurora, Colorado
  • +2 more
Nov 1, 2016

Breast Cancer Trial in Edinburgh (RG1507)

Completed
  • Breast Cancer
  • RG1507
  • Edinburgh, United Kingdom
    (unnamed)
Nov 1, 2016

Tumors Trial in New York, San Antonio, Milano (RAD001, RG1507)

Terminated
  • Neoplasms
  • New York, New York
  • +2 more
Nov 1, 2016

Tumors Trial in United States (RG1507, RO1507, bevacizumab [Avastin])

Terminated
  • Neoplasms
  • RG1507
  • +16 more
  • Tucson, Arizona
  • +7 more
Nov 1, 2016

NSCLC Trial in Worldwide (RG1507, erlotinib [Tarceva])

Terminated
  • Non-Small Cell Lung Cancer
  • RG1507
  • erlotinib [Tarceva]
  • Santa Monica, California
  • +15 more
Jun 19, 2013